Hilton Grand Vacations vs Hilton Worldwide
HGV and HLT side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HGV and HLT compare
Hilton Worldwide is the larger company, worth 24 times as much as Hilton Grand Vacations ($82.4B against $3.4B).
On earnings, Hilton Grand Vacations is cheaper: it trades at 8.7× trailing earnings, against 50.0× for Hilton Worldwide.
Hilton Grand Vacations grew revenue faster over the last twelve months (18.8% versus 8.1% for Hilton Worldwide).
Hilton Worldwide keeps more of each dollar of sales as profit, with a net margin of 13.4% compared with 7.0% at Hilton Grand Vacations.
Hilton Worldwide pays a dividend yielding 0.16%; Hilton Grand Vacations does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HGV | HLT |
|---|---|---|
| Size and price | ||
| Market cap | $3.4B | $82.4B |
| Share price | $45.42 | $370.53 |
| Change, 1 year | 15.4% | 37.4% |
| Change, 5 years | −7.7% | 172% |
| Beta (5Y) | 1.03 | 0.43 |
| Employees | 22K | 259K |
| StockData Score | ||
| Total score | 10 | 10 |
| Valuation score | 5 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 3 | 3 |
| Health score | 0 | 1 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 8.7× (better) | 50.0× |
| P/S | 0.6× (better) | 6.5× |
| P/B | 2.6× | – |
| EV/EBITDA | 2.8× (better) | 29.3× |
| P/FCF | 7.3× (better) | 42.7× |
| PEG | – | 4.74 |
| FCF yield | 13.7% (better) | 2.3% |
| Fair value | $112.41 | $205.17 |
| Margin of safety | 59.6% (better) | −80.6% |
| Growth | ||
| Revenue growth (TTM) | 18.8% (better) | 8.1% |
| Revenue growth, 5Y average | 41.4% (better) | 22.8% |
| Net income growth (TTM) | 687% (better) | 2.1% |
| EPS growth (TTM) | 829% (better) | 7.1% |
| Profitability | ||
| Operating margin | – | 24.0% |
| Net margin | 7.0% | 13.4% (better) |
| FCF margin | 8.0% | 15.2% (better) |
| Return on equity | 31.0% | – |
| Return on invested capital | – | 38.1% |
| Financial health | ||
| Net debt / EBITDA | – | 3.88 |
| Interest coverage | – | 4.4× |
| Current ratio | – | 0.59 |
| Altman Z-score | 0.72 | 3.30 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | – | 0.16% |
| Payout ratio | – | 8.1% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | 32.0% |
| Buyback yield | 16.3% (better) | 4.1% |
| Shareholder yield | 16.3% (better) | 4.3% |
| Ownership | ||
| Held by institutions | 111% | 96.2% |
| Held by insiders | 35.4% | 1.6% |
| Insider net buying, 12 months | −$14.7M (better) | −$98.3M |
| Superinvestors holding | 1 | 3 (better) |
| Short interest, % of float | 28.4% | 2.4% |
Go deeper
- HGV stock overview
- HGV income statement
- HGV valuation and score
- HLT stock overview
- HLT income statement
- HLT valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.